Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Public ClinicalTrials.gov record NCT02709746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Evaluating the efficacy of vortioxetine 10 mg/day and 20 mg/day versus placebo on depressive symptoms in adolescents (age ≥12 and ≤17 years) with a DSM-5™ (Diagnostic and Statistical Manual of Mental Disorders, 5th edition) diagnosis of Major depressive disorder (MDD).
Study identification
- NCT ID
- NCT02709746
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 784 participants
Conditions and interventions
Conditions
Interventions
- Vortioxetine 10 mg/day Drug
- Vortioxetine 20 mg/day Drug
- Fluoxetine 20 mg/day Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2016 (Type not available)
- Primary completion
- Jul 2, 2019 (Actual)
- Completion
- Jul 30, 2019 (Actual)
- Last update posted
- Aug 19, 2020
2016 – 2019
United States locations
- U.S. sites
- 42
- U.S. states
- 20
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US1369 | Dothan | Alabama | — | — |
| US1333 | Tucson | Arizona | — | — |
| US1310 | Little Rock | Arkansas | — | — |
| US1062 | Costa Mesa | California | — | — |
| US1387 | Downey | California | — | — |
| US1114 | Escondido | California | — | — |
| US1118 | Glendale | California | — | — |
| US1123 | Imperial | California | — | — |
| US1160 Renew Behavioral Health, Inc. | Long Beach | California | — | — |
| US1368 | Orange | California | — | — |
| US1370 | Panorama City | California | — | — |
| US1351 | Wildomar | California | — | — |
| US1133 | Washington D.C. | District of Columbia | — | — |
| US1217 | Gainesville | Florida | — | — |
| US1229 | Orange City | Florida | — | — |
| US1009 | Atlanta | Georgia | — | — |
| US1313 | Marietta | Georgia | — | — |
| US1311 | Naperville | Illinois | — | — |
| US1315 | Naperville | Illinois | — | — |
| US1103 | Oak Brook | Illinois | — | — |
| US1386 | Wichita | Kansas | — | — |
| US1261 | Lake Charles | Louisiana | — | — |
| US1015 | Baltimore | Maryland | — | — |
| US1385 Ericksen Research And Development | Clinton | Mississippi | — | — |
| US1064 | Creve Coeur | Missouri | — | — |
| US1314 | O'Fallon | Missouri | — | — |
| US1266 | Saint Charles | Missouri | — | — |
| US1312 | Berlin | New Jersey | — | — |
| US1222 | Princeton | New Jersey | — | — |
| US1317 | New York | New York | — | — |
| US1171 | Rochester | New York | — | — |
| US1190 | Staten Island | New York | — | — |
| US1051 | Cincinnati | Ohio | — | — |
| US1054 | Cleveland | Ohio | — | — |
| US1334 | Middleburg Heights | Ohio | — | — |
| US1323 | Oklahoma City | Oklahoma | — | — |
| US1329 | Oklahoma City | Oklahoma | — | — |
| US1328 | Austin | Texas | — | — |
| US1320 | Plano | Texas | — | — |
| US1162 | San Antonio | Texas | — | — |
| US1308 | Orem | Utah | — | — |
| US1309 | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 82 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02709746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2020 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02709746 live on ClinicalTrials.gov.